Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials
出版年份 2022 全文链接
标题
Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials
作者
关键词
-
出版物
SCHIZOPHRENIA BULLETIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2022-10-06
DOI
10.1093/schbul/sbac138
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
- (2022) Johannes Schneider-Thoma et al. LANCET
- Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia
- (2021) Kazunari Yoshida et al. BEHAVIOURAL BRAIN RESEARCH
- A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
- (2021) Mark Abie Horowitz et al. SCHIZOPHRENIA BULLETIN
- Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia
- (2021) Stefan Leucht et al. JAMA Psychiatry
- Confounding of Antipsychotic Discontinuation Studies by Withdrawal-Related Relapse
- (2021) Mark Abie Horowitz et al. SCHIZOPHRENIA BULLETIN
- Limitations in Research on Maintenance Treatment for Individuals With Schizophrenia
- (2021) Mark Abie Horowitz et al. JAMA Psychiatry
- Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
- (2020) Maximilian Huhn et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Risk factors for psychotic relapse after dose reduction or discontinuation of antipsychotics in patients with chronic schizophrenia. A systematic review and meta-analysis
- (2020) Jan P A M Bogers et al. SCHIZOPHRENIA BULLETIN
- Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials
- (2019) Hideaki Tani et al. NEUROPSYCHOPHARMACOLOGY
- Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review
- (2019) Joanna Moncrieff et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms
- (2019) Yutaro Shimomura et al. SCHIZOPHRENIA RESEARCH
- Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
- (2019) Joanna Moncrieff et al. BMJ Open
- Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study
- (2018) Yanling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
- (2018) Christoph U. Correll et al. World Psychiatry
- Management of common adverse effects of antipsychotic medications
- (2018) T. Scott Stroup et al. World Psychiatry
- Does Half-Life Matter After Antipsychotic Discontinuation?
- (2017) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHIATRY
- Improving outcomes of first-episode psychosis: an overview
- (2017) Paolo Fusar-Poli et al. World Psychiatry
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
- (2017) Jari Tiihonen et al. JAMA Psychiatry
- Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study
- (2016) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Altering the course of schizophrenia: progress and perspectives
- (2016) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Age-related changes in binding of the D 2/3 receptor radioligand [ 11 C](+)PHNO in healthy volunteers
- (2016) David Matuskey et al. NEUROIMAGE
- Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey
- (2016) Takuro Sugai et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic medication in schizophrenia: a review
- (2015) John Lally et al. BRITISH MEDICAL BULLETIN
- The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
- (2015) Marc De Hert et al. CNS DRUGS
- Antipsychotic Maintenance Treatment: Time to Rethink?
- (2015) Joanna Moncrieff PLOS MEDICINE
- Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method
- (2015) Y. Yamanouchi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Relapse Duration, Treatment Intensity, and Brain Tissue Loss in Schizophrenia: A Prospective Longitudinal MRI Study
- (2013) Nancy C. Andreasen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study
- (2013) H. Takeuchi et al. SCHIZOPHRENIA BULLETIN
- Are there clinically useful predictors and early warning signs for pending relapse?
- (2013) Wolfgang Gaebel et al. SCHIZOPHRENIA RESEARCH
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Safety and tolerability of antipsychotic polypharmacy
- (2012) Juan A Gallego et al. Expert Opinion On Drug Safety
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study
- (2012) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern Finland 1966 Birth Cohort study
- (2011) J. Moilanen et al. EUROPEAN PSYCHIATRY
- Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial
- (2010) Chuan-Yue Wang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
- (2009) John M. Kane et al. AMERICAN JOURNAL OF PSYCHIATRY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Schizophrenia, “just the facts” 4. Clinical features and conceptualization
- (2009) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Strategies of treatment with olanzapine in schizophrenic patients during stable phase: Results of a pilot study
- (2008) Frédéric Rouillon et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More